Compare Franklin FTSE South Korea ETF (FLKR) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Franklin FTSE South Korea ETF vs ImmunityBio Inc. Common Stock — how do they compare? Franklin FTSE South Korea ETF trades at $58.27 (market cap $1.83B), while ImmunityBio Inc. Common Stock trades at $10.28 (market cap $10.51B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 5.7× Franklin FTSE South Korea ETF's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Franklin FTSE South Korea ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Franklin FTSE South Korea ETF for 15 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| FLKR | IBRX | |
|---|---|---|
Market Cap | $1.83B | $10.51B |
Volume | 679,902 | 10,445,785 |
Sector | Broad Market / Factor | Health |
52-Week High | $72.25 | $11.55 |
52-Week Low | $27.09 | $1.98 |
Typical Hold Time | 15 Days | 0 Days |
Enterprise Value | — | $10.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Franklin FTSE South Korea ETF
Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →
